CN102430011B - Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof - Google Patents
Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof Download PDFInfo
- Publication number
- CN102430011B CN102430011B CN2011104103592A CN201110410359A CN102430011B CN 102430011 B CN102430011 B CN 102430011B CN 2011104103592 A CN2011104103592 A CN 2011104103592A CN 201110410359 A CN201110410359 A CN 201110410359A CN 102430011 B CN102430011 B CN 102430011B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- parts
- moxibustion
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, comprising the bulk drugs in part by weight: 5-10 parts of moxa, 0.5-1.5 parts of frankincense, 0.5-1.5 parts of myrrh, 0.5-1.5 parts of agilawood, 0.5-1.5 parts of borneol and 0.5-1.5 parts of cassia twig. The invention also provides a preparation method and applications of the traditional Chinese medicinal composition. The invention has the advantages that the double treatment action of moxa and traditional Chinese medicine is played, the clinic curative effect is greatly improved, the power is continuous and permeated, and the warm range is large, so that the invention is applicable to various cold syndromes, asthenia syndrome, painful syndrome and stasis syndrome, can be used for treating various common diseases and difficult miscellaneous diseases on clinic, and also can be used for daily health care; and in the invention, the carrying is convenient, the operation is easy, the price is far lower than that of the common clinic diagnosis, and considerable economic benefit can be brought.
Description
Technical field
The present invention relates to medical treatment and healthcare field, specifically, is a kind of Chinese medicine composition for traditional Chinese medical science moxibustion and its preparation method and application.
Background technology
" moxibustion " is exactly the meaning of burning.Moxibustion is to sum up a kind of Therapeutic Method of coming out during the Ancient Times in China people wage a struggle with disease.China people have grasped the method with fire time immemorial, people may be burnt accidentally once in a while and burn, and alleviate some slight illness in cooking food and heating; Or the roasting abdominal part that burns, alleviated symptoms such as the cold pain of abdominal part and distension, so everybody initiatively with burning the more disease for the treatment of of burning, has so just produced moxibustion." pin can't be obtained, the institute of moxibustion should " be arranged in " Ling Shu Miraculous Pivot or Divine Axis official can ", the curative effect effect of moxibustion just has been described.In the ancient times of China, because moxibustion is in the remarkable effect for the treatment of in the disease, and easily to seek with the convenience of moxibustion material, moxibustion is being prevailing very at that time, has obtained very big development with material and the treatment technology of moxibustion.Material with moxibustion: the one, with some zest Chinese herb medicine; The 2nd, the Folium Artemisiae Argyi of special-purpose burning or used other some medicines as the material of burning.The development for the treatment of technology: the monograph " Cao Shi moxibustion side " (lost) that has just occurred moxibustion as far back as the period of Three Kingdoms, the Song dynasty village is ample to be had " region below the heart acupuncture points on the human body moxibustion therapy ", the well-known figure has " preemergency moxibustion side ", west that " courtyart moxibustion warp " arranged over sixty years of age, have in the wide blessing of Ming Dynasty's leaf " adopting Chinese mugwort compile ", the Wu of the Qing Dynasty is influential moxibustion monograph in history such as ancient cooking vessel " refreshing moxibustion is through opinion " also.
Chinese patent literature CN100450513C discloses a kind of traditional Chinese medical science moxibustion medication and preparation method thereof, Chinese medicinal components comprises Radix Aucklandiae 20-40%, Folium Artemisiae Argyi 30-50%, Lignum Santali Albi 10-20%, Rhizoma Acori Graminei 5-10%, Radix Angelicae Dahuricae 4-8%, Rhizoma Atractylodis 5-10%, Olibanum 0.5-1%, Myrrha 0.5-1%, Cortex ulmi pumilae 1-1.5%, make Chinese medicine Moxibustion strip or moxa-moxibustion rod, the collection moxibustion is cured the disease, health body-building, incense and one.Chinese patent literature CN1231228C discloses a kind of medicine moxibustion goods with promoting flow of QI and blood pain relieving effect, formed by Olibanum 30g, Rhizoma Chuanxiong 30g, Rhizoma Corydalis 50g, Sanguis Draxonis 30g, Stigma Croci 20g, Borneolum Syntheticum 10g, Moschus 5g and Folium Artemisiae Argyi 500g, be used for the treatment of the diseases such as stomach, intestinal, liver, gallbladder pain and dysmenorrhea of qi depression to blood stasis.Prior art mostly is used for making common clear moxa roll, the main component of common clear moxa roll is Folium Artemisiae Argyi, wherein there is not Chinese medicine ingredients, the moxibustion product that contains Chinese medicine on a small quantity is usually used in treating clinical common disease and daily health caring, to difficult miscellaneous disease DeGrain often, and the using method of these products is limited, and clinical indication is also limited.
Summary of the invention
The objective of the invention is at deficiency of the prior art, a kind of Chinese medicine composition for traditional Chinese medical science moxibustion is provided.
One purpose more of the present invention is, a kind of preparation method of the Chinese medicine composition for traditional Chinese medical science moxibustion is provided.
Another purpose of the present invention is, a kind of application of the Chinese medicine composition for traditional Chinese medical science moxibustion is provided.
For achieving the above object, the technical scheme that the present invention takes is: a kind of Chinese medicine composition for traditional Chinese medical science moxibustion, described Chinese medicine composition is made up of following bulk drugs: Folium Artemisiae Argyi 5-15 part, Olibanum 0.5-1.5 part, Myrrha 0.5-1.5 part, Lignum Aquilariae Resinatum 0.5-1.5 part, Borneolum Syntheticum 0.5-1.5 part, Ramulus Cinnamomi 0.5-1.5 part.
Described Chinese medicine composition is made up of following bulk drugs: Folium Artemisiae Argyi 8-12 part, Olibanum 0.8-1.2 part, Myrrha 0.8-1.2 part, Lignum Aquilariae Resinatum 0.8-1.2 part, Borneolum Syntheticum 0.8-1.2 part, Ramulus Cinnamomi 0.8-1.2 part.
Described Chinese medicine composition is made up of following bulk drugs: 10 parts of Folium Artemisiae Argyis, 1 part of Olibanum, 1 part of Myrrha, 1 part of Lignum Aquilariae Resinatum, 1 part of Borneolum Syntheticum, 1 part of Ramulus Cinnamomi.
Described Chinese medicine composition also comprises following bulk drugs: Moschus 0.5-1.5 part, Squama Manis 0.5-1.5 part, Herba speranskiae tuberculatae 0.5-1.5 part, Rhizoma Homalomenae 0.5-1.5 part.
Described Chinese medicine composition also comprises following bulk drugs: Moschus 0.8-1.2 part, Squama Manis 0.8-1.2 part, Herba speranskiae tuberculatae 0.8-1.2 part, Rhizoma Homalomenae 0.8-1.2 part.
Described Chinese medicine composition also comprises following bulk drugs: 1 part in Moschus, 1 part of Squama Manis, 1 part of Herba speranskiae tuberculatae, 1 part of Rhizoma Homalomenae.
For realizing above-mentioned second purpose, the technical scheme that the present invention takes is: a kind of preparation method of the Chinese medicine composition for traditional Chinese medical science moxibustion, described preparation method may further comprise the steps: get one on cotton mulberry paper, long 20-30 centimetre, the weighting profit requires the arbitrary described Chinese medicine composition medicamental pulverata 21-24 gram of 1-6, be rolled into the cylinder of diameter 18-30mm, the thick paste of external mulberry paper 6-7 layer, it is stand-by to dry in the shade.
For realizing above-mentioned the 3rd purpose, the technical scheme that the present invention takes is: the application of described Chinese medicine composition in the medicine of preparation treatment intractable facial paralysis, facial paralysis sequela, arthritis, chronic pharyngolaryngitis, chronic fatigue syndrome.
The invention has the advantages that:
1, the present invention has brought into play Folium Artemisiae Argyi and the effect of Chinese medicine double treatment, improves clinical efficacy greatly;
2, diameter of the present invention is greater than common clear moxa roll, firepower continues, infiltration, warmth and heat scope is big, be applicable to various cold syndrome, deficiency syndrome, pain card, blood stasis syndrome, can be used to treat clinical each section's commonly encountered diseases and difficult miscellaneous diseases, as treat intractable facial paralysis, facial paralysis sequela, arthritis, chronic pharyngolaryngitis, chronic fatigue syndrome etc., and can use daily health caring;
3, easy to carry, the using method easy operating can use in the family, is not limited to doctor and medical space, and price is used if obtain popularizing far below common clinic diagnosis price simultaneously, can alleviate social problems such as " difficulty and high cost of getting medical, the high costs of getting medical treatment " of current society;
Therefore 4. the present invention is consumable goods, and clinical wideling popularize with being extensive use of of family health care not only can bring glad tidings to the patient, can also bring considerable economic.
The specific embodiment
Below the specific embodiment provided by the invention is elaborated.
The invention provides a kind of Chinese medicine composition for traditional Chinese medical science moxibustion, described Chinese medicine composition is made up of following bulk drugs: Folium Artemisiae Argyi 5-10 part, Olibanum 0.5-1.5 part, Myrrha 0.5-1.5 part, Lignum Aquilariae Resinatum 0.5-1.5 part, Borneolum Syntheticum 0.5-1.5 part, Ramulus Cinnamomi 0.5-1.5 part.
Embodiment 1 Chinese medicine composition one ()
5 parts of Folium Artemisiae Argyis, 1.5 parts of Olibanums, 0.5 part of Myrrha, 1.5 parts of Lignum Aquilariae Resinatum, 0.5 part of Borneolum Syntheticum, 1.5 parts of Ramulus Cinnamomi.
Embodiment 2 Chinese medicine compositions one (two)
6 parts of Folium Artemisiae Argyis, 1.4 parts of Olibanums, 0.6 part of Myrrha, 1.4 parts of Lignum Aquilariae Resinatum, 0.6 part of Borneolum Syntheticum, 1.4 parts of Ramulus Cinnamomi.
Embodiment 3 Chinese medicine compositions one (three)
7 parts of Folium Artemisiae Argyis, 1.3 parts of Olibanums, 0.7 part of Myrrha, 1.3 parts of Lignum Aquilariae Resinatum, 0.7 part of Borneolum Syntheticum, 1.3 parts of Ramulus Cinnamomi.
Embodiment 4 Chinese medicine compositions one (four)
8 parts of Folium Artemisiae Argyis, 1.2 parts of Olibanums, 0.8 part of Myrrha, 1.2 parts of Lignum Aquilariae Resinatum, 0.8 part of Borneolum Syntheticum, 1.2 parts of Ramulus Cinnamomi.
Embodiment 5 Chinese medicine compositions one (five)
9 parts of Folium Artemisiae Argyis, 1.1 parts of Olibanums, 0.9 part of Myrrha, 1.1 parts of Lignum Aquilariae Resinatum, 0.9 part of Borneolum Syntheticum, 1.1 parts of Ramulus Cinnamomi.
Embodiment 6 Chinese medicine compositions one (six)
10 parts of Folium Artemisiae Argyis, 1 part of Olibanum, 1 part of Myrrha, 1 part of Lignum Aquilariae Resinatum, 1 part of Borneolum Syntheticum, 1 part of Ramulus Cinnamomi.
Embodiment 7 Chinese medicine compositions one (seven)
11 parts of Folium Artemisiae Argyis, 0.9 part of Olibanum, 1.1 parts of Myrrhas, 0.9 part of Lignum Aquilariae Resinatum, 1.1 parts of Borneolum Syntheticums, 0.9 part of Ramulus Cinnamomi.
Embodiment 8 Chinese medicine compositions one (eight)
12 parts of Folium Artemisiae Argyis, 0.8 part of Olibanum, 1.2 parts of Myrrhas, 0.8 part of Lignum Aquilariae Resinatum, 1.2 parts of Borneolum Syntheticums, 0.8 part of Ramulus Cinnamomi.
Embodiment 9 Chinese medicine compositions one (nine)
13 parts of Folium Artemisiae Argyis, 0.7 part of Olibanum, 1.3 parts of Myrrhas, 0.7 part of Lignum Aquilariae Resinatum, 1.3 parts of Borneolum Syntheticums, 0.7 part of Ramulus Cinnamomi.
Embodiment 10 Chinese medicine compositions one (ten)
14 parts of Folium Artemisiae Argyis, 0.6 part of Olibanum, 1.4 parts of Myrrhas, 0.6 part of Lignum Aquilariae Resinatum, 1.4 parts of Borneolum Syntheticums, 0.6 part of Ramulus Cinnamomi.
Embodiment 11 Chinese medicine compositions one (11)
15 parts of Folium Artemisiae Argyis, 0.5 part of Olibanum, 1.5 parts of Myrrhas, 0.5 part of Lignum Aquilariae Resinatum, 1.5 parts of Borneolum Syntheticums, 0.5 part of Ramulus Cinnamomi.
A kind of Chinese medicine composition for traditional Chinese medical science moxibustion, described Chinese medicine composition is made up of following bulk drugs: Folium Artemisiae Argyi 5-10 part, Olibanum 0.5-1.5 part, Myrrha 0.5-1.5 part, Lignum Aquilariae Resinatum 0.5-1.5 part, Borneolum Syntheticum 0.5-1.5 part, Ramulus Cinnamomi 0.5-1.5 part, Moschus 0.5-1.5 part, Squama Manis 0.5-1.5 part, Herba speranskiae tuberculatae 0.5-1.5 part, Rhizoma Homalomenae 0.5-1.5 part.
Embodiment 12 Chinese medicine compositions one ()
5 parts of Folium Artemisiae Argyis, 1.5 parts of Olibanums, 0.5 part of Myrrha, 1.5 parts of Lignum Aquilariae Resinatum, 0.5 part of Borneolum Syntheticum, 1.5 parts of Ramulus Cinnamomi, 0.5 part in Moschus, 1.5 parts of Squama Maniss, 0.5 part of Herba speranskiae tuberculatae, 1.5 parts of Rhizoma Homalomenaes.
Embodiment 13 Chinese medicine compositions one (two)
6 parts of Folium Artemisiae Argyis, 1.4 parts of Olibanums, 0.6 part of Myrrha, 1.4 parts of Lignum Aquilariae Resinatum, 0.6 part of Borneolum Syntheticum, 1.4 parts of Ramulus Cinnamomi, 0.6 part in Moschus, 1.4 parts of Squama Maniss, 0.6 part of Herba speranskiae tuberculatae, 1.4 parts of Rhizoma Homalomenaes.
Embodiment 14 Chinese medicine compositions one (three)
7 parts of Folium Artemisiae Argyis, 1.3 parts of Olibanums, 0.7 part of Myrrha, 1.3 parts of Lignum Aquilariae Resinatum, 0.7 part of Borneolum Syntheticum, 1.3 parts of Ramulus Cinnamomi, 0.7 part in Moschus, 1.3 parts of Squama Maniss, 0.7 part of Herba speranskiae tuberculatae, 1.3 parts of Rhizoma Homalomenaes.
Embodiment 15 Chinese medicine compositions one (four)
8 parts of Folium Artemisiae Argyis, 1.2 parts of Olibanums, 0.8 part of Myrrha, 1.2 parts of Lignum Aquilariae Resinatum, 0.8 part of Borneolum Syntheticum, 1.2 parts of Ramulus Cinnamomi, 0.8 part in Moschus, 1.2 parts of Squama Maniss, 0.8 part of Herba speranskiae tuberculatae, 1.2 parts of Rhizoma Homalomenaes.
Embodiment 16 Chinese medicine compositions one (five)
9 parts of Folium Artemisiae Argyis, 1.1 parts of Olibanums, 0.9 part of Myrrha, 1.1 parts of Lignum Aquilariae Resinatum, 0.9 part of Borneolum Syntheticum, 1.1 parts of Ramulus Cinnamomi, 0.9 part in Moschus, 1.1 parts of Squama Maniss, 0.9 part of Herba speranskiae tuberculatae, 1.1 parts of Rhizoma Homalomenaes.
Embodiment 17 Chinese medicine compositions one (six)
10 parts of Folium Artemisiae Argyis, 1 part of Olibanum, 1 part of Myrrha, 1 part of Lignum Aquilariae Resinatum, 1 part of Borneolum Syntheticum, 1 part of Ramulus Cinnamomi, 1 part in Moschus, 1 part of Squama Manis, 1 part of Herba speranskiae tuberculatae, 1 part of Rhizoma Homalomenae.
Embodiment 18 Chinese medicine compositions one (seven)
11 parts of Folium Artemisiae Argyis, 0.9 part of Olibanum, 1.1 parts of Myrrhas, 0.9 part of Lignum Aquilariae Resinatum, 1.1 parts of Borneolum Syntheticums, 0.9 part of Ramulus Cinnamomi, 1.1 parts in Moschus, 0.9 part of Squama Manis, 1.1 parts of Herba speranskiae tuberculataes, 0.9 part of Rhizoma Homalomenae.
Embodiment 19 Chinese medicine compositions one (eight)
12 parts of Folium Artemisiae Argyis, 0.8 part of Olibanum, 1.2 parts of Myrrhas, 0.8 part of Lignum Aquilariae Resinatum, 1.2 parts of Borneolum Syntheticums, 0.8 part of Ramulus Cinnamomi, 1.2 parts in Moschus, 0.8 part of Squama Manis, 1.2 parts of Herba speranskiae tuberculataes, 0.8 part of Rhizoma Homalomenae.
Embodiment 20 Chinese medicine compositions one (nine)
13 parts of Folium Artemisiae Argyis, 0.7 part of Olibanum, 1.3 parts of Myrrhas, 0.7 part of Lignum Aquilariae Resinatum, 1.3 parts of Borneolum Syntheticums, 0.7 part of Ramulus Cinnamomi, 1.3 parts in Moschus, 0.7 part of Squama Manis, 1.3 parts of Herba speranskiae tuberculataes, 0.7 part of Rhizoma Homalomenae.
Embodiment 21 Chinese medicine compositions one (ten)
14 parts of Folium Artemisiae Argyis, 0.6 part of Olibanum, 1.4 parts of Myrrhas, 0.6 part of Lignum Aquilariae Resinatum, 1.4 parts of Borneolum Syntheticums, 0.6 part of Ramulus Cinnamomi, 1.4 parts in Moschus, 0.6 part of Squama Manis, 1.4 parts of Herba speranskiae tuberculataes, 0.6 part of Rhizoma Homalomenae.
Embodiment 22 Chinese medicine compositions one (11)
15 parts of Folium Artemisiae Argyis, 0.5 part of Olibanum, 1.5 parts of Myrrhas, 0.5 part of Lignum Aquilariae Resinatum, 1.5 parts of Borneolum Syntheticums, 0.5 part of Ramulus Cinnamomi, 1.5 parts in Moschus, 0.5 part of Squama Manis, 1.5 parts of Herba speranskiae tuberculataes, 0.5 part of Rhizoma Homalomenae.
Embodiment 23 is used for the preparation method of the Chinese medicine composition of traditional Chinese medical science moxibustion
Get one on cotton mulberry paper, long 20-30 centimetre, get the arbitrary described Chinese medicine composition medicamental pulverata 21-24 gram of embodiment 1-22, volume is as the firecracker formula, and is more tight more good, is rolled into the cylinder of diameter 18-30mm, the thick paste of external mulberry paper 6-7 layer, it is stand-by to dry in the shade.
Embodiment 24 usings method
Common moxa-moxibustion: be usually used in lighting the rear overhang moxibustion, apart from the 2cm left and right sides moxibustion of top, acupuncture point, firepower is of short duration, and warmth and heat scope is limited;
Taiyi moxibustion (being the present invention): can hang moxibustion by similar common moxa roll, but firepower is lasting, warmth and heat scope is obviously greater than common moxa stick moxibustion.Can also adopt pressing moxibustion, with Taiyi moxibustion one end points combustion, 6～7 layers of tissue paper of place mat or cotton on the moxibustion position, or wrap the Chinese mugwort fire with 6～7 layers of cotton, the fire that will end is directly pressed on the moxibustion position, puts out as if fire, presses again again, and press 5～7 times in each every cave.The firepower of pressing moxibustion continues, infiltration, and warmth and heat scope is bigger, better efficacy.
Embodiment 25 the present invention treat the clinical trial of facial paralysis
1. clinical data
1.1 physical data: object of study is selected 60 routine obstinate facial paralysis patients of hospital outpatient.Women's 35 examples wherein, male's 25 examples.Age of onset 19-56 year, 21 ± 2.3 years old mean age.The course of disease 1 month-60 months, average course of disease 18 ± 2.6 months.Be divided into four groups at random, one group of 15 example of Taiyi moxibustion wherein, two group of 15 example of Taiyi moxibustion, common moxa roll group 16 examples, blank group 14 examples.
1.2 diagnostic criteria: the diagnostic criteria that " combination of Chinese and Western medicine evaluation of infranuclear facial palsy and criterion of therapeutical effect (draft) " (hereinafter to be referred as " standard (draft) ") that diagnostic criteria adopts CAIM (Chinese Association Of Integrative Medicine) department of neurology Professional Committee to work out worked out: (1) Ipsilateral volume stricture of vagina in various degree disappears, it is unable to frown, hypophasis; (2) can not alarm nose, nasolabial fold shoals, and philtrum ditch, lip are crooked to strong side; (3) the Ipsilateral bicker descends, mouthful cheek food entrapment.
1.3 the standard of including in: 1. meet the diagnostic criteria of peripheral facial paralysis, and through western medical treatment DeGrain person; 2. male or female, the age is in 18-80 year; 3. use the patient of moxibustion treatment voluntarily.
1.4 exclusion standard: 1. the course of disease is person within 1 month; 2. be diagnosed as the patient of central facial palsy; 3. merge to have the inclination, serious primary disease and psychotics such as liver, kidney and hemopoietic system.
1.5 rejecting standard: 1. all treatments or adopt beyond the acupuncture influential other therapies of efficacy result according to the rules; 2. can't judge that curative effect or data are not congruent affects the treatment or safety judgement person; 3. initiatively end the patient of moxibustion treatment.
2. research method
2.1 Therapeutic Method
One group of Taiyi moxibustion: prepare Chinese medicine composition one with reference to embodiment 6 and embodiment 23 described methods, use with reference to embodiment 24 described methods, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Two groups of Taiyi moxibustions: prepare Chinese medicine composition two with reference to embodiment 17 and embodiment 23 described methods, use with reference to embodiment 24 described methods, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Common moxa roll group: common Folium Artemisiae Argyi hangs moxibustion, once a day, and each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Blank group: will not treat.
2.2 observation index
Every treatment is observed patient's clinical symptoms improvement situation after 1 course for the treatment of.
3. criterion of therapeutical effect
Reference " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ":
Cure: symptom and sign disappearance, close one's eyes, rouse the cheek, move complete symmetry normally grinningly;
Take a turn for the better: symptom and sign take a turn for the better, and close one's eyes, the drum cheek, action makes moderate progress grinningly;
Do not heal: symptom and sign no change.
5. therapeutic effect
Result of the test sees the following form.Effective percentage=(curing number+produce effects number+significant figure)/total number of persons.
The comparison of the four groups of patient's clinical efficacies in table 1 treatment back
| Group | The example number | Cure | Produce effects | Effectively | Invalid | Inefficiency % | Total effective rate % |
| One group of Taiyi moxibustion | 15 | 5 | 6 | 2 | 3 | 20.00 | 80.00*# |
| Two groups of Taiyi moxibustions | 15 | 9 | 4 | 1 | 1 | 6.67 | 93.33*# |
| Common moxa roll group | 16 | 5 | 2 | 4 | 5 | 31.25 | 68.75# |
| The blank group | 14 | 0 | 0 | 2 | 12 | 85.71 | 14.29 |
Annotate: * represents to compare P＜0.05 with common moxa roll group; # represents to compare P＜0.05 with the blank group.
Through the treatments of three courses for the treatment of and follow up a case by regular visits to, the result shows that the Taiyi moxibustion cures 5 people for one group, produce effects 6 people, effective 2 people, invalid 3 people, total effective rate 80.00%.The Taiyi moxibustion is cured 9 people for two groups, produce effects 4 people, effective 1 people, invalid 1 people, total effective rate 93.33%.Compare with the blank group, the total effective rate of one group of Taiyi moxibustion, two groups of Taiyi moxibustions and common moxa roll group all significantly is better than the blank group, P＜0.05, and difference has statistical significance.Compare with common moxa roll group, the total effective rate that one group of Taiyi moxibustion and Taiyi moxibustion are two groups all significantly is better than common moxa roll group, P＜0.05, and difference has statistical significance.The clinical efficacy that Chinese medicine composition one and the obstinate facial paralysis of Chinese medicine composition two treatments are described significantly is better than common moxa roll.
Tangible adverse events does not take place in four groups of patients during treating.Tangible hepatic and renal function injure does not appear, serious disease in the blood system and cordis and cerebral accident event.The treatment that Chinese medicine composition one and Chinese medicine composition two are described does not have obvious harmful effect to the patient.
The clinical trial of embodiment 26 treatment of arthritis of the present invention
1. clinical data
1.1 physical data: object of study is selected 67 routine gonarthritis patients of hospital outpatient.Women's 40 examples wherein, male's 27 examples.Age of onset 40-66 year, 55 ± 2 years old mean age.The course of disease 0.5 year-10 years.Be divided into four groups at random, one group of 17 example of Taiyi moxibustion wherein, two group of 17 example of Taiyi moxibustion, common moxa roll group 17 examples, blank group 16 examples.
1.2 diagnostic criteria: adopt the knee osteoarthritis diagnostic criteria of nineteen ninety-five Americanism damp disease association revision: there is gonalgia (1) preceding 1 month most of times; (2) the bone sound is arranged during joint motion; (3) morning, deadlock was less than 30 minutes; (4) age was more than or equal to 38 years old; (5) the knee joint inspection has the bone hypertrophy.Satisfy the 1+2+3+4 bar, or 1+2+5 bar or 1+4+5 person, diagnosable is knee osteoarthritis.Clinical and radiology: there is gonalgia (1) preceding 1 month most of times; (2) the X line shows edge, joint hyperosteogeny; (3) the joint fluid lab testing meets osteoarthritis; (4) age was more than or equal to 40 years old; (5) morning, deadlock was less than 30 minutes; (6) the bone sound is arranged during joint motion.Satisfy 1+2 bar or 1+3+5+6 bar, or 1+4+5+6 bar person, diagnosable knee osteoarthritis.
1.3 the standard of including in: 1. meet the diagnostic criteria of knee osteoarthritis, and through western medical treatment DeGrain person; 2. male or female, the age was at 〉=38 years old; 3. use the patient of moxibustion treatment voluntarily.
1.4 exclusion standard: 1. the age was less than 38 years old person; 2. be diagnosed as the patient of non-knee osteoarthritis; 3. merge to have the inclination, serious primary disease and psychotics such as liver, kidney and hemopoietic system.
1.5 rejecting standard: 1. all treatments or adopt beyond the acupuncture influential other therapies of efficacy result according to the rules; 2. can't judge that curative effect or data are not congruent affects the treatment or safety judgement person; 3. initiatively end the patient of moxibustion treatment.
2. research method
2.1 Therapeutic Method
One group of Taiyi moxibustion: prepare Chinese medicine composition one with reference to embodiment 6 and embodiment 23 described methods, use with reference to embodiment 24 described methods, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Two groups of Taiyi moxibustions: prepare Chinese medicine composition two with reference to embodiment 17 and embodiment 23 described methods, use with reference to embodiment 24 described methods, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Common moxa roll group: common Folium Artemisiae Argyi, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Blank group: will not treat.
2.2 observation index
Every treatment is observed patient's clinical symptoms improvement situation after 1 course for the treatment of.
3. criterion of therapeutical effect
Reference " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ":
Cure: symptom and sign disappear;
Take a turn for the better: symptom and sign take a turn for the better;
Do not heal: symptom and sign no change.
5. therapeutic effect
Result of the test sees the following form.Effective percentage=(curing number+produce effects number+significant figure)/total number of persons.
The comparison of the four groups of patient's clinical efficacies in table 2 treatment back
| Group | The example number | Cure | Produce effects | Effectively | Invalid | Inefficiency % | Total effective rate % |
| One group of Taiyi moxibustion | 17 | 7 | 6 | 1 | 3 | 17.65 | 82.35*# |
| Two groups of Taiyi moxibustions | 17 | 10 | 4 | 1 | 2 | 11.76 | 88.24*# |
| Common moxa roll group | 17 | 6 | 2 | 4 | 5 | 29.41 | 70.59# |
| The blank group | 16 | 0 | 0 | 1 | 15 | 85.71 | 14.29 |
Annotate: * represents to compare P＜0.05 with common moxa roll group; # represents to compare P＜0.05 with the blank group.
Through the treatments of three courses for the treatment of and follow up a case by regular visits to, the result shows that the Taiyi moxibustion cures 7 people for one group, produce effects 6 people, effective 1 people, invalid 3 people, total effective rate 82.35%.The Taiyi moxibustion is cured 10 people for two groups, produce effects 4 people, effective 1 people, invalid 2 people, total effective rate 88.24%.Compare with the blank group, the total effective rate of one group of Taiyi moxibustion, two groups of Taiyi moxibustions and common moxa roll group all significantly is better than the blank group, P＜0.05, and difference has statistical significance.Compare with common moxa roll group, the total effective rate that one group of Taiyi moxibustion and Taiyi moxibustion are two groups all significantly is better than common moxa roll group, P＜0.05, and difference has statistical significance.The clinical efficacy that Chinese medicine composition one and Chinese medicine composition two treatment gonarthritis are described significantly is better than common moxa roll.
Tangible adverse events does not take place in four groups of patients during treating.Tangible hepatic and renal function injure does not appear, serious disease in the blood system and cordis and cerebral accident event.The treatment that Chinese medicine composition one and Chinese medicine composition two are described does not have obvious harmful effect to the patient.
Embodiment 27 the present invention treat the clinical trial of chronic fatigue syndrome
1. clinical data
1.1 physical data: object of study is selected 80 routine chronic fatigue syndrome patients of hospital outpatient.Women's 38 examples wherein, male's 42 examples.Age of onset 22-60 year, 37 ± 4.5 years old mean age.The course of disease 1 month to 12 years.Be divided into four groups at random, one group of 20 example of Taiyi moxibustion wherein, two group of 20 example of Taiyi moxibustion, common moxa roll group 20 examples, blank group 20 examples.
1.2 diagnostic criteria: adopt the chronic fatigue syndrome diagnostic criteria of the Center for Disease Control in 1994 revision: (1) clinical evaluation inexplicable continues or showed effect repeatedly 6 months or the confirmed fatigue of longer time.This fatigue is new or clear and definite beginning (long less than the vital stage) is arranged; Not to continue result firmly; After having a rest, can not obviously alleviate; Cause work, education, society or individual activity level before to significantly decrease.(2) occur simultaneously more than 4 or 4 in the following symptom, and these symptoms have continued to exist or showed effect repeatedly 6 months or the longer time, but should be early than fatigue: 1. impermanent memory power or the obvious decline of focusing one's attention on; 2. pharyngalgia; 3. the enlargement of cervical region or axillary lymph knot, tenderness; 4. myalgia; 5. there is not red and swollen multiarticulate pain; 6. one type of new, that degree is heavy headache; 7. the sleep that can not recover from fatigue; 8. post exercise is tired continued above 24 hours.
1.3 the standard of including in: 1. meet the diagnostic criteria of chronic fatigue syndrome, and through western medical treatment DeGrain person; 2. male or female, the age is in 18-80 year; 3. use the patient of moxibustion treatment voluntarily.
1.4 exclusion standard: 1. the course of disease is person within 6 months; The patient that 2. clinical clear and definite medical diagnosis on disease is arranged; 3. merge to have the inclination, serious primary disease and psychotics such as liver, kidney and hemopoietic system.
1.5 rejecting standard: 1. all treatments or adopt beyond the acupuncture influential other therapies of efficacy result according to the rules; 2. can't judge that curative effect or data are not congruent affects the treatment or safety judgement person; 3. initiatively end the patient of moxibustion treatment.
2. research method
2.1 Therapeutic Method
One group of Taiyi moxibustion: prepare Chinese medicine composition one with reference to embodiment 6 and embodiment 23 described methods, use with reference to embodiment 24 described methods, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Two groups of Taiyi moxibustions: prepare Chinese medicine composition two with reference to embodiment 17 and embodiment 23 described methods, use with reference to embodiment 24 described methods, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Common moxa roll group: common Folium Artemisiae Argyi, once a day, each 30 minutes.10 next courses for the treatment of, treat 3 courses for the treatment of altogether.
Blank group: will not treat.
2.2 observation index
Every treatment is observed patient's clinical symptoms improvement situation after 1 course for the treatment of.
3. criterion of therapeutical effect
Reference " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ":
Cure: symptom and sign disappear;
Take a turn for the better: symptom and sign take a turn for the better;
Do not heal: symptom and sign no change.
5. therapeutic effect
Result of the test sees the following form.Effective percentage=(curing number+produce effects number+significant figure)/total number of persons.
The comparison of the four groups of patient's clinical efficacies in table 3 treatment back
| Group | The example number | Cure | Produce effects | Effectively | Invalid | Inefficiency % | Total effective rate % |
| One group of Taiyi moxibustion | 20 | 10 | 3 | 5 | 2 | 10.00 | 90.00*# |
| Two groups of Taiyi moxibustions | 20 | 12 | 5 | 3 | 0 | 0 | 100*# |
| Common moxa roll group | 20 | 7 | 5 | 5 | 3 | 15.00 | 75.00# |
| The blank group | 20 | 0 | 0 | 2 | 18 | 90.00 | 10.00 |
Annotate: * represents to compare P＜0.05 with common moxa roll group; # represents to compare P＜0.05 with the blank group.
Through the treatments of three courses for the treatment of and follow up a case by regular visits to, the result shows that the Taiyi moxibustion cures 10 people for one group, produce effects 3 people, effective 5 people, invalid 2 people, total effective rate 90.00%.The Taiyi moxibustion is cured 12 people for two groups, produce effects 5 people, effective 3 people, invalid 0 people, total effective rate 100%.Compare with the blank group, the total effective rate of one group of Taiyi moxibustion, two groups of Taiyi moxibustions and common moxa roll group all significantly is better than the blank group, P＜0.05, and difference has statistical significance.Compare with common moxa roll group, the total effective rate that one group of Taiyi moxibustion and Taiyi moxibustion are two groups all significantly is better than common moxa roll group, P＜0.05, and difference has statistical significance.The clinical efficacy that Chinese medicine composition one and Chinese medicine composition two treatment chronic fatigue syndromes are described significantly is better than common moxa roll.
Tangible adverse events does not take place in four groups of patients during treating.Tangible hepatic and renal function injure does not appear, serious disease in the blood system and cordis and cerebral accident event.The treatment that Chinese medicine composition one and Chinese medicine composition two are described does not have obvious harmful effect to the patient.
Discuss:
1. Taiyi moxibustion of the present invention is that Chinese medicine is joined in the common moxa roll, and performance Folium Artemisiae Argyi and the effect of Chinese medicine double treatment improve clinical efficacy greatly.
2. the diameter of Taiyi moxibustion is greater than common clear moxa roll, firepower continues, infiltration, warmth and heat scope is big, as the medicine of Taiyi moxibustion moxibustion, mostly is the hot fragrant circulation of qi promoting of selecting for use simultaneously, blood circulation promoting and blood stasis dispelling, warming YANG to expel cold, the crystalline substance of removing obstruction in the collateral to relieve pain is applicable to various cold syndrome, deficiency syndrome, pain card, blood stasis syndrome, can be used to treat clinical each section's commonly encountered diseases and difficult miscellaneous diseases, and can use daily health caring.
3. the Taiyi moxibustion is easy to carry, and the using method easy operating can use in the family, be not limited to doctor and medical space, price is used if obtain popularizing far below common clinic diagnosis price simultaneously, can alleviate social problems such as " difficulty and high cost of getting medical, the high costs of getting medical treatment " of current society.
Therefore 4. the Taiyi moxibustion is consumable goods, and clinical wideling popularize with being extensive use of of family health care not only can bring glad tidings to the patient, can also bring considerable economic.
At present, the correlational study of clinical use Taiyi moxibustion finds that the clinical efficacy of Taiyi moxibustion treatment intractable facial paralysis, facial paralysis sequela, arthritis, chronic pharyngolaryngitis, chronic fatigue syndrome etc. significantly is better than common moxa roll.
The above only is preferred implementation of the present invention; should be pointed out that for those skilled in the art, under the prerequisite that does not break away from the inventive method; can also make some improvement and replenish, these improvement and replenish and also should be considered as protection scope of the present invention.
Claims (8)
1. Chinese medicine composition that is used for traditional Chinese medical science moxibustion, it is characterized in that described Chinese medicine composition is made up of following bulk drugs: Folium Artemisiae Argyi 5-15 part, Olibanum 0.5-1.5 part, Myrrha 0.5-1.5 part, Lignum Aquilariae Resinatum 0.5-1.5 part, Borneolum Syntheticum 0.5-1.5 part, Ramulus Cinnamomi 0.5-1.5 part.
2. Chinese medicine composition according to claim 1, it is characterized in that described Chinese medicine composition is made up of following bulk drugs: Folium Artemisiae Argyi 8-12 part, Olibanum 0.8-1.2 part, Myrrha 0.8-1.2 part, Lignum Aquilariae Resinatum 0.8-1.2 part, Borneolum Syntheticum 0.8-1.2 part, Ramulus Cinnamomi 0.8-1.2 part.
3. Chinese medicine composition according to claim 1 is characterized in that, described Chinese medicine composition is made up of following bulk drugs: 10 parts of Folium Artemisiae Argyis, 1 part of Olibanum, 1 part of Myrrha, 1 part of Lignum Aquilariae Resinatum, 1 part of Borneolum Syntheticum, 1 part of Ramulus Cinnamomi.
4. according to the arbitrary described Chinese medicine composition of claim 1-3, it is characterized in that described Chinese medicine composition also comprises following bulk drugs: Moschus 0.5-1.5 part, Squama Manis 0.5-1.5 part, Herba speranskiae tuberculatae 0.5-1.5 part, Rhizoma Homalomenae 0.5-1.5 part.
5. according to the arbitrary described Chinese medicine composition of claim 1-3, it is characterized in that described Chinese medicine composition also comprises following bulk drugs: Moschus 0.8-1.2 part, Squama Manis 0.8-1.2 part, Herba speranskiae tuberculatae 0.8-1.2 part, Rhizoma Homalomenae 0.8-1.2 part.
6. according to the arbitrary described Chinese medicine composition of claim 1-3, it is characterized in that described Chinese medicine composition also comprises following bulk drugs: 1 part in Moschus, 1 part of Squama Manis, 1 part of Herba speranskiae tuberculatae, 1 part of Rhizoma Homalomenae.
7. preparation method that is used for the Chinese medicine composition of traditional Chinese medical science moxibustion, it is characterized in that, described preparation method may further comprise the steps: get one on cotton mulberry paper, long 20-30 centimetre, the weighting profit requires the arbitrary described Chinese medicine composition medicamental pulverata 21-24 gram of 1-6, be rolled into the cylinder of diameter 18-30mm, the thick paste of external mulberry paper 6-7 layer, it is stand-by to dry in the shade.
8. according to the application of the arbitrary described Chinese medicine composition of claim 1-6 in the medicine of preparation treatment intractable facial paralysis, facial paralysis sequela, arthritis, chronic pharyngolaryngitis, chronic fatigue syndrome.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104103592A CN102430011B (en) | 2011-12-12 | 2011-12-12 | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104103592A CN102430011B (en) | 2011-12-12 | 2011-12-12 | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102430011A CN102430011A (en) | 2012-05-02 |
| CN102430011B true CN102430011B (en) | 2013-08-28 |
Family
ID=45978596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104103592A Active CN102430011B (en) | 2011-12-12 | 2011-12-12 | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102430011B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893545B (en) * | 2014-03-13 | 2016-05-25 | 许伯宗 | A kind of moxa stick that improves brain health and preparation method thereof |
| CN105560611A (en) * | 2015-11-24 | 2016-05-11 | 丁明 | Umbilical external plaster and preparation method thereof |
| CN105726672A (en) * | 2016-02-17 | 2016-07-06 | 赵时全 | Drug efficacy induction moxibustion moxa sticks and preparing method thereof |
| CN105943644B (en) * | 2016-06-29 | 2019-11-22 | 上海市针灸经络研究所 | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain |
| CN106176197A (en) * | 2016-07-07 | 2016-12-07 | 南阳纯爱香颂美容有限公司 | A kind of cervical region health preserving moxibustion suit and using method thereof |
| CN106075363A (en) * | 2016-07-29 | 2016-11-09 | 左国庆 | A kind of moxibustion Qizhong drug composition with enhancing immunity and moxibustion umbilicus method |
| CN106344855A (en) * | 2016-08-29 | 2017-01-25 | 张东旭 | Medium for external use of moxibustiontherapy through traditional Chinese medicine and preparing method thereof |
| CN106215157A (en) * | 2016-08-29 | 2016-12-14 | 张东旭 | A kind of auxiliary moxibustion Chinese medicine oil and preparation method thereof |
| CN108498772A (en) * | 2018-06-04 | 2018-09-07 | 广东阳宗易中医药科技发展有限公司 | Medical moxibustion composition and preparation method thereof for whole body conditioning |
| CN114288235B (en) * | 2022-01-21 | 2023-02-03 | 江苏省中医院 | Traditional Chinese medicine composition for moxibustion and preparation method and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1255372A (en) * | 1999-11-30 | 2000-06-07 | 徐增乐 | Moxiburning ointment and its preparing process and application |
-
2011
- 2011-12-12 CN CN2011104103592A patent/CN102430011B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1255372A (en) * | 1999-11-30 | 2000-06-07 | 徐增乐 | Moxiburning ointment and its preparing process and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102430011A (en) | 2012-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102430011B (en) | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof | |
| CN103565876B (en) | A kind of medicinal moxa roll and uses thereof | |
| CN103127253A (en) | Chinese medicinal capsules for treating catagmatic blood stasis and preparation method thereof | |
| CN101507802A (en) | Medicine for treating ankylosing spondylitis | |
| CN100548343C (en) | A kind of medicine and preparation technology thereof who treats Feng Han Shi Paralysis, hyperosteogeny, intervertebral disk hernia | |
| CN101073575B (en) | Capsule for treating acne | |
| CN102688363B (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN103690605A (en) | Traditional Chinese medicine preparation for treating rheumatism | |
| CN107625944A (en) | Warm application of a kind of ginger folium artemisiae argyi cervical vertebra and preparation method thereof | |
| CN106492105A (en) | A kind of treat the Chinese medicine that type dizziness is disturbed on wind-phlegm | |
| CN102988559B (en) | Chinese medicinal enema for treating ulcerative colitis | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN101244181B (en) | Plaster for bone paralysis with function of qufengshengshi, blood circulation activating and stasis removing, and removing the obstruction in the channels to relieve pain, and preparation thereof | |
| CN103893480A (en) | Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility | |
| CN105125814B (en) | It is a kind of to treat chronic renal failure III, the Chinese medicine composition of IV phase | |
| CN104224946B (en) | A kind of pharmaceutical composition for the treatment of deficiency of the liver and kindey | |
| CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
| CN103301424B (en) | Traditional Chinese medicine composition for activating meridians to stop pain for therapy of medicinal cupping and application thereof | |
| CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
| CN103432333B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism | |
| CN116942740B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and application thereof | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN102430094B (en) | Traditional Chinese medicine decoction for treating angina pectoris | |
| CN1067576C (en) | Medicine for treating burn and scald | |
| CN104825708A (en) | External application plaster with effects of blood circulation activating, arthromyodynia dredging, wind-evil dispelling, dampness removing, tendon relaxing, and collateral dredging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |